Introduction {#s1}
============

Evolutionary pressures for survival in fluctuating environments that expose organisms to times of both feast and famine have selected for the ability to efficiently store and release energy in the form of triacylglycerol (TAG). However, excessive or defective lipid storage is a key feature of common diseases such as diabetes, atherosclerosis, and the metabolic syndrome ([@bib23]). The organelles that are essential for storing and mobilizing intracellular fat are lipid droplets (LDs) ([@bib65]). They constitute a unique cellular structure where a core of neutral lipids is stabilized in the hydrophilic cytosol by a phospholipid monolayer embedding LD proteins. While most mammalian cells present small LDs (\<1 μm) ([@bib61]), white (unilocular) adipocytes contain a single giant LD that occupies most of their cell volume. In contrast, brown (multilocular) adipocytes hold multiple LDs of smaller size that increase the LD surface/volume ratio, which facilitates the rapid consumption of lipids for adaptive thermogenesis ([@bib15]).

The exploration of new approaches for the treatment of metabolic disorders has been stimulated by the rediscovery of active brown adipose tissue (BAT) in adult humans ([@bib64]; [@bib16]) and by the induction of multilocular brown-like cells in white adipose tissue (WAT) ([@bib29]). The multilocular morphology of brown adipocytes is a defining characteristic of these cells along with expression of genes such as Ucp1. The acquisition of a unilocular or multilocular phenotype is likely to be controlled by the regulation of LD growth. Two related proteins, CIDEA and CIDEC, promote LD enlargement in adipocytes ([@bib71]; [@bib52]; [@bib53]), with CIDEA being specifically found in BAT. Together with CIDEB, they form the CIDE (cell death-inducing DFF45-like effector) family of LD proteins, which have emerged as important metabolic regulators ([@bib72]).

Different mechanisms have been proposed for LD enlargement, including in situ neutral lipid synthesis, lipid uptake, and LD--LD coalescence ([@bib39]; [@bib69]; [@bib9]). The study of CIDE proteins has revealed a critical role in the LD fusion process in which a donor LD progressively transfers its content to an acceptor LD until it is completely absorbed ([@bib21]). However, the underlying mechanism by which CIDEC and CIDEA facilitate the interchange of TAG molecules between LDs is not understood. In the present study, we have obtained a detailed picture of the different steps driving this LD enlargement process, which involves the stabilization of LD pairs, phospholipid binding, and the permeabilization of the LD monolayer to allow the transference of lipids.

Results {#s2}
=======

CIDEA expression mimics the LD dynamics observed during the differentiation of brown adipocytes {#s2-1}
-----------------------------------------------------------------------------------------------

To examine the processes controlling LD enlargement in brown adipocytes, we followed LD dynamics using time-lapse microscopy. During differentiation of immortalized brown pre-adipocytes, large LDs were formed by the fusion of pre-existing LDs ([Video 1](#media1){ref-type="other"}). This fusion process was characterized by a slow and progressive reduction in the volume of a donor LD until it was completely absorbed by an acceptor LD ([Figure 1A](#fig1){ref-type="fig"}), which is characteristic of CIDE activity. As CIDEA is selectively expressed in brown adipocytes and could have a prominent role in the acquisition of their multilocular morphology, we explored the effects of its expression in undifferentiated pre-adipocytes. After inducing CIDEA, LDs in pre-adipocytes showed an equivalent dynamic pattern to that observed in differentiating brown cells, with the progressive fusion of the initial LDs until a few large LDs remained in the cell ([Video 2](#media2){ref-type="other"}). LD fusion was achieved by the slow transference of lipids between LDs, and was preceded by the formation of small clusters of interacting LDs ([Figure 1B](#fig1){ref-type="fig"}). Given the importance of this process in adipocyte dynamics, we decided to undertake a comprehensive molecular analysis.Video 1.Lipid droplet (LD) enlargement in differentiating immortalized brown adipose tissue (imBAT) cells.Immortalized brown pre-adipocytes were induced to differentiate by incubation for 48 hr + 6 hr with the described differentiation cocktails. The cell displays the characteristic LD enlargement pattern triggered by CIDE proteins, defined by the progressive fusion by lipid transference of the pre-existing LDs.**DOI:** [http://dx.doi.org/10.7554/eLife.07485.003](10.7554/eLife.07485.003)10.7554/eLife.07485.00310.7554/eLife.07485.004Figure 1.CIDEA promotes lipid droplet (LD) enlargement by transference of lipids.(****A****) Live imaging of the LD dynamics during the differentiation of a brown pre-adipocyte, showing the characteristic CIDE-triggered LD enlargement, characterized by the progressive transference of lipids from a donor to an acceptor LD until it is completely absorbed. (****B****) Live imaging of the LD dynamics in an undifferentiated 3T3-L1 cell 6 hr after infection with adenoviral particles carrying the Cidea gene. Red arrows highlight the transient formation of irregularly shaped LD clusters, while yellow arrows mark the fusion of two droplets by transference of lipids. (****C****) CIDEA-v5 expression in Hela cells induces LD enlargement. An enrichment in CIDEA-v5 (red) can be observed in the contact site between two LDs (green). (****D****) Detail of LD fusion by slow transference of lipids in a 3T3-L1 cell stably expressing CIDEA-v5.**DOI:** [http://dx.doi.org/10.7554/eLife.07485.004](10.7554/eLife.07485.004)Video 2.Lipid droplet (LD) enlargement induced by CIDEA.LD dynamics in undifferentiated 3T3-L1 cells 6 hr after infection with adenoviral particles carrying the mouse Cidea gene. After CIDEA induction, the initial individual LDs form stable contacts reflected by small irregularly shaped clusters of LDs. These interacting LDs undergo an enlargement process by lipid transference, characterized by the progressive enlargement of the acceptor LD and shrinkage of the donor LD until only a few large LDs remain in the cell.**DOI:** [http://dx.doi.org/10.7554/eLife.07485.005](10.7554/eLife.07485.005)10.7554/eLife.07485.005

Phases of CIDEA activity: LD targeting, LD--LD docking, and LD growth {#s2-2}
---------------------------------------------------------------------

The ectopic expression of full-length CIDEA induced the formation of large LDs through LD fusion by lipid transfer ([Figure 1C,D](#fig1){ref-type="fig"}). Control cells, which lacked expression of CIDEA, did not show LD enlargement ([Figure 1C](#fig1){ref-type="fig"}). As many proteins are constructed of domains, which are conserved across families and serve as their main structural and functional units, we assessed the conserved regions within the CIDE proteins. By comparing the 217 amino acid (aa) sequence of CIDEA with that of CIDEB and CIDEC, four highly conserved regions could be identified ([Figure 2A](#fig2){ref-type="fig"} and [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). The N-terminal (N-term) domain of CIDEA is composed of a basic region (2--72 aa) followed by an acidic sequence (73--110 aa). These distinctly differently charged regions are indicated by protein crystallography studies to be important for the dimerization of CIDE domain proteins ([@bib43]; [@bib67]; [@bib60]; [@bib40]). The CIDEA C-terminal (C-term) is rich in basic aas and contains a highly conserved region (126--155 aa) and a basic and hydrophobic sequence (162--197 aa). Based on this sequence analysis, we created an extensive collection of v5-tagged CIDE point and deletion mutants to test their effects on LDs ([Figure 2](#fig2){ref-type="fig"}). Interestingly, certain mutations such as R171E/R175E promoted the aggregation of the cellular LDs in a few \'bunch of grapes\'-like LD clusters, but were unable to induce the transference of lipids between them ([Figure 2B](#fig2){ref-type="fig"}). In other cases, as with the expression of CIDEA-(116--217)-v5, the LDs remained small and dispersed throughout the cytoplasm despite the protein being normally localized at their surface. Finally, some versions of CIDEA, such as CIDEA-(1--118)-v5, showed no LD localization and did not affect their size, number, or distribution. Together with the time-lapse results, this indicates that the molecular mechanism of CIDEA is composed of three discrete phases: LD targeting, LD--LD docking, and LD growth.10.7554/eLife.07485.006Figure 2.Mapping the functional domains of CIDEA.(****A****) Amino acid (aa) sequence of murine CIDEA highlighting the residues conserved in either CIDEB or CIDEC (grey underline), or in both proteins (black underline). The substituted aa in mutant constructs appear in red, and a positively charged sequence necessary for the TAG transfer step is encircled in orange. Four highly conserved regions are defined and symbolized by colour boxes in a linear representation of CIDEA-v5. The theoretical isoelectric point of each fragment is indicated inside the boxes. (****B****) Representative images of the different phenotypes observed in Hela cells overexpressing mutated forms of CIDEA-v5 24 hr after transfection cells were treated with oleic acid and incubated for further 18 hr prior to fixation. Cells were classified into six major phenotypes. Cells expressing fully active forms of CIDEA had few and large LDs (Type I). In some mutants, the large LDs remained attached to many small LDs, indicating that lipid transfer was inefficient or inactive for some LDs (Type II). When CIDEA alterations blocked the lipid transfer process, the LDs remained small and grouped in a few large clusters (Type III). If this was accompanied by inefficient LD--LD docking, the cells contained a number of small LD clusters combined with isolated LDs (Type IV). The CIDEA forms that could not stabilize LD--LD interactions displayed a phenotype similar to the mock transfected cells, with most of the LDs dispersed through the cytoplasm (Type V). Finally, some CIDEA constructs were unable to target the LDs, indicating an alteration of the LD-binding domain (Type VI). (****C****) Morphologic distribution of cells expressing each of the studied CIDE constructs. The phenotypic distribution was performed in a minimum of three independent experiments for every construct (n\>50 cells).**DOI:** [http://dx.doi.org/10.7554/eLife.07485.006](10.7554/eLife.07485.006)10.7554/eLife.07485.007Figure 2---figure supplement 1.Alignment of amino acid sequences of CIDEA, CIDEB, and CIDEC.Clustal format alignment of murine CIDEA, CIDEB, and CIDEC, performed using T-COFFEE ([www.tcoffee.org](www.tcoffee.org)). Amino acid sequences were obtained from <http://ensembl.org>. \"\*\" means residues are identical in all sequences in the alignment; \":\" means conserved substitutions have been observed, \".\" means that semi-conserved substitutions are observed. Four highly conserved regions are defined by colour boxes.**DOI:** [http://dx.doi.org/10.7554/eLife.07485.007](10.7554/eLife.07485.007)

A cationic amphipathic helix in C-term drives LD targeting {#s2-3}
----------------------------------------------------------

All the CIDEA constructs that showed impaired LD localization contained deletions or mutations in the C-term hydrophobic and basic region (162--197 aa) ([Figure 2C](#fig2){ref-type="fig"}). In fact, the last 66 aas of CIDEA were sufficient for LD localization, as shown with the expression of CIDEA-(152--217)-v5, whereas it lacked the ability to facilitate the docking of LDs ([Figures 2C](#fig2){ref-type="fig"} and [4A](#fig4){ref-type="fig"}). Although it is known that the C-term domain of CIDE proteins is essential for LD localization and enlargement ([@bib42]; [@bib14]), only the structure of the N-term domain has been solved ([@bib43]; [@bib67]; [@bib60]; [@bib40]). The CIDE-N domain (Pfam reference PF02017) has been determined in members of the CIDE family (PBD Codes: 2eel (hCIDEA), 1D4B (hCIDEB), 4MAC (mCIDEC), 4ikg (mCIDEC)) to aas 40--117, 34--100, and 41--118 in hCIDEA, hCIDEB, and mCIDEC, respectively. Thus, the sequence 163--180 that we found essential for LD targeting ([Figure 2C](#fig2){ref-type="fig"}) lacks direct structural information to date. We therefore predicted its structure using in silico approaches. The region displayed high probability of a helical conformation with a strongly amphipathic character ([Figure 3A,B](#fig3){ref-type="fig"}, and [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). To experimentally confirm the presence of an amphipathic helix in the LD-targeting domain of CIDEA, circular dichroism (CD) spectroscopy was used to estimate the secondary structure of a synthetic peptide corresponding to residues 158--185 in CIDEA. The CD spectra in the presence of 0.1% n-dodecyl-β-D-maltopyranoside confirmed the presence of α-helical structure ([Figure 3C](#fig3){ref-type="fig"}).10.7554/eLife.07485.008Figure 3.CIDEA targets the LD monolayer through a cationic amphipathic helix.(****A****) Secondary structure of CIDEA predicted by SWISS-MODEL server. (****B****) Helical wheel representation of the putative amphipathic α-helix (163--180) generated at <http://heliquest.ipmc.cnrs.fr/>. (****C****) Circular dichroism (CD) spectra of a 28-aa peptide corresponding to the 158--185 sequence of CIDEA (41 μM) solubilized in 50 mM potassium phosphate, pH 6.2 plus 0.1% n-dodecyl-β-D-maltopyranoside. (****D****) A Hela cell expressing HA-CIDEA-(1--120)-v5 (red) or HA-CIDEA-(1--117)-(163--180) (red), showing the inclusion of aas 163--180 enhances LD localization and the ability to promote LD docking. The phenotypic distribution was performed in a minimum of three independent experiments for every construct (n\>50 cells). HA signal in LDs was only detected in a proportion of the cells where HA-CIDEA constructs had induced LD enlargement or clustering, possibly due to the formation of CIDEA complexes reducing antibody accessibility to the HA epitope at the N-term. (****E****) A Hela cell expressing CIDEA-(F166R/V169R/L170R)-v5 (red) showing aa substitutions to compromise amphipathicity of the helix disrupt LD targeting, and a Hela cell expressing CIDEA-(K167E/R171E/R175/E)-v5 (red) showing amino acid (aa) substitutions to invert the charge of the helix but maintaining amphipathicity retains predominantly LD localization.**DOI:** [http://dx.doi.org/10.7554/eLife.07485.008](10.7554/eLife.07485.008)10.7554/eLife.07485.009Figure 3---figure supplement 1.Conservation of amino acids (aas) for CIDEA amphipathic helix across vertebrate species.(****A****) Alignment of aa sequences for CIDEA over a range of vertebrate species corresponding to the amphipathic α-helix (murine aas 163--180). Amino acid sequences were obtained from <http://ensembl.org> and initially aligned using WebPRANK at <http://ebi.ac.uk>. Sequences were then grouped based on species phylogeny. (****B****) Helical wheel representation of the CIDEA putative amphipathic α-helix for indicated species (corresponding to murine aas 163--180) generated at <http://heliquest.ipmc.cnrs.fr/>.**DOI:** [http://dx.doi.org/10.7554/eLife.07485.009](10.7554/eLife.07485.009)10.7554/eLife.07485.010Figure 4.Liquid droplet (LD)--LD docking and CIDEA interactions.(****A****) A Hela cell expressing CIDEA-(152--217)-v5 showing normal recruitment to LDs, but no LD docking. A Hela cell expressing CIDEA-△(126--155)-v5 showing normal LD--LD docking but inefficient LD enlargement as revealed by the presence of clusters of small and large LDs. Representative images are shown of experiments performed in a minimum of three independent experiments for every construct (n\>50 cells). (****B****) Co-immunoprecipitation (co-IP) assays between CIDEA-HA and different CIDEA-v5 constructs. The observed CIDEA--CIDEA interaction was driven by the C-term domain and required the presence of the 126--155 aa sequence. (****C, D****) Co-IP assays showing CIDEA interactions with CIDEB, CIDEC, and PLIN5. Each co-IP assay was performed at least in triplicate, producing similar results in each experiment.**DOI:** [http://dx.doi.org/10.7554/eLife.07485.010](10.7554/eLife.07485.010)

As some LD proteins are known to be bound to the LD membrane through amphipathic helices ([@bib31]; [@bib37]), we tested if this short sequence was sufficient for LD targeting. While HA-(1--120)-CIDEA showed no LD localization and had no effect on LD distribution or size, HA-CIDEA-(1--117)-(163--180) was partially localized on the LD surface and promoted LD clustering ([Figure 3D](#fig3){ref-type="fig"}). Furthermore, the deletion of this C-term sequence in CIDEA-△(163--179)-v5 completely eliminated LD localization in most of the cells ([Figure 2B,C](#fig2){ref-type="fig"}), confirming its role in LD targeting. However, partial LD localization could be observed in a small percentage of cells, together with the presence of LD clusters. This was also observed in CIDEA-△(162--197)-v5 and was particularly frequent in CIDEA-(N172X)-v5, which contains a deletion in the middle of the helix. In contrast, no LD targeting could be observed for the N-term fragment alone (1--118 aa) ([Figure 2C](#fig2){ref-type="fig"}). This may indicate that other regions in C-term may contribute to LD localization either by directly binding the LD membrane or by interacting with other LD proteins. Similarly, LD targeting was compromised when the amphipathic character of the helix was disrupted in CIDEA-(F166R/V169R/L170R)-v5 by introducing cationic aas in its hydrophobic face. Although LD localization was only lost in a small percentage of cells, in the remaining cells the LD staining was accompanied by a predominantly cytosolic localization ([Figures 2C](#fig2){ref-type="fig"} and [3E](#fig3){ref-type="fig"}). In contrast, the predominant LD localization of wild type (wt) CIDEA was maintained in CIDEA-(K167E/R171E/R175E)-v5, which presents a charge inversion of the helix but maintains its amphipathic properties ([Figures 2C](#fig2){ref-type="fig"} and [3E](#fig4){ref-type="fig"}).

The amphipathic helix is essential for LD enlargement {#s2-4}
-----------------------------------------------------

In addition to its role in LD targeting, our data indicate that the cationic amphipathic helix in the C-term participates in the TAG transference step of CIDEA activity, as the charge inversion (K167E/R171E/R175E) did not affect LD targeting but completely blocked LD enlargement ([Figure 2C](#fig2){ref-type="fig"}). Despite not being essential for LD targeting, the cationic aas in the helix are highly conserved in vertebrates [Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}. K167 is 100% conserved across all vertebrate species examined. R171 was conserved across vertebrates including birds, snakes, lizards, crocodiles, turtles, marsupials, placental mammals, and monotremes, although not in fish. R175 is also highly conserved, with only birds, dolphins, and the Nile Tilapia (a fish) lacking this residue. Remarkably, an amphipathic helix is predicted in CIDEA of all the vertebrate species examined ([Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}).

The absence of negative charges in the helix appeared to be an essential condition to permit TAG transference, as a single inverted charge mutation such as R171E or R175E was sufficient to block LD enlargement ([Figure 2C](#fig2){ref-type="fig"}). In contrast, conservative substitutions such as R171K or K167R did not affect CIDEA activity, and even the substitution of the three basic aas with histidine in (K167H/R171H/R175H)-CIDEA-v5 was compatible with the formation of large LDs, strongly supporting the conclusion from sequence comparison that positive charges are required at these positions. As histidine has a lower pKa value than arginine and lysine, it can carry a positive charge depending on the pH and local environment, which could explain the activity retained by this protein.

LD--LD docking is induced by the formation of CIDEA complexes {#s2-5}
-------------------------------------------------------------

Deletions in the N-term domain of CIDEA impaired LD--LD docking, as shown by the increase in cells displaying isolated LDs ([Figure 2C](#fig2){ref-type="fig"}). Furthermore, LD clustering could be induced by forcing the LD localization of the N-term fragment through conjugation with the 18-aa amphipathic helix (HA-CIDEA-(1--117)-(162--180)) ([Figure 3C](#fig3){ref-type="fig"}).

As the N-term of CIDEA forms a highly polarized structure that is prone to dimerize ([@bib43]), we hypothesized that LD--LD docking was induced by the N-term--N-term interaction of CIDEA molecules in adjacent LDs (trans complexes). However, the C-term fragment (116--217) retained some degree of LD--LD docking activity ([Figure 2C](#fig2){ref-type="fig"}), indicating that an additional interaction site could be present in this region. In fact, a complete blocking of LD clustering was only observed with the shorter fragment 152--217, which lacks the N-term and a section of the C-term ([Figure 4A](#fig4){ref-type="fig"}).

The formation of CIDEA--CIDEA complexes was confirmed by co-immunoprecipitation (co-IP) of CIDEA-v5 with CIDEA-HA. Surprisingly, co-IP was observed with CIDEA-(116--217)-v5 but not CIDEA-(1--118)-v5, indicating that the C-term was responsible for that interaction ([Figure 4B](#fig4){ref-type="fig"}). Interestingly, a similar percentage of the input was co-immunoprecipitated for constructs producing highly clustered LDs (CIDEA-(R171E/R175E)-v5) and constructs showing few LD--LD contacts (CIDEA-v5 or CIDEA-(116--217)-v5). Hence, this C-term interaction is largely independent of the presence of LD--LD contacts, indicating that it may also occur in cis.

Within the C-term region, the deletion of the 162--197 sequence did not affect the co-IP whereas the signal was largely reduced in CIDEA-△(126--155)-v5 ([Figure 4B](#fig4){ref-type="fig"}), indicating that this conserved region was involved in the C-term interaction. However, the residual interaction still detectable by co-IP could sustain the LD-docking activity, as cells expressing this construct displayed normal LD clustering ([Figure 4A,B](#fig4){ref-type="fig"}). CIDEA-(152--217)-v5 ([Figures 2](#fig2){ref-type="fig"} and [4A](#fig4){ref-type="fig"}), which showed no LD clustering and lacked both the 126--155 interaction site and the N-term domain, displayed a further reduction on the co-IP signal ([Figure 4B](#fig4){ref-type="fig"}). Therefore, trans complexes through N-term dimerization would be responsible for the LD clusters and weak co-IP signal observed in CIDEA-(126--155)-v5. The lack of co-IP between the N-term fragment and the full-length CIDEA could be due to conformational and positional factors favouring the interaction between the HA-tagged full-length proteins in the LD or between the cytosolic v5-tagged N-term fragments. In fact, co-IP between N-term fragments of CIDEC was previously reported ([@bib60]). This interaction could be disrupted with the point mutations E87Q/D88N or R55E as predicted by the crystal structure of the N-term fragment, which reveals the formation of homodimers in which the positively charged R46, R55, and R56 in one molecule interact with negative residues in the other (E87 and D88) ([@bib60]). Interestingly, we found that the equivalent mutations in CIDEA (E79Q/D80N and R47E) impaired LD docking, while R47Q and R47A, which would not create repulsions between the interacting domains, did not affect CIDEA activity ([Figure 2C](#fig2){ref-type="fig"}). Taken together, these results suggest that both the C-term dimerization site (126--155) and the N-term domain of CIDEA can contribute to LD--LD docking by forming complexes with its counterparts on the adjacent LD.

CIDEC differs from CIDEA in its dependence on the N-term domain {#s2-6}
---------------------------------------------------------------

The differential expression of CIDEA and CIDEC in BAT and WAT could be related to the acquisition of multilocular or unilocular morphologies in brown and white adipocytes ([@bib5]). While the ectopic expression of both CIDEA and CIDEC produce LD enlargement in a similar manner, specific differences in their activity and regulation could achieve discrete outcomes. In fact, whereas deletion of the N-term domain of CIDEA blocks LD enlargement ([Figure 2C](#fig2){ref-type="fig"}), it has been described that the C-term fragment of CIDEC retains its activity ([@bib21]; [@bib34]). Here we show that similar to CIDEA, the N-term of CIDEC is involved in LD--LD docking, as its deletion increases the fraction of cells displaying isolated LDs ([Figure 2C](#fig2){ref-type="fig"}). However, in the cells where the C-term of CIDEC could effectively induce LD--LD docking, large LDs were observed instead of LD clusters, showing that although its docking efficiency is reduced, this region of CIDEC is sufficient for docking and enlarging the LDs. This differs from CIDEA, in which the C-term fragment cannot induce LD enlargement despite retaining a partial LD docking activity. In addition to the intrinsic differences between CIDEC and CIDEA, their activity could be affected by the interaction with additional proteins. While PLIN1 interacts with CIDEC, but not CIDEA, and potentiates its activity ([@bib60]; [@bib22]), we have observed that CIDEA interacts with PLIN5 ([Figure 4D](#fig4){ref-type="fig"}), which is rich in BAT ([@bib29]; [@bib74]). In addition to PLIN5, CIDEA showed high affinity for both CIDEB and CIDEC, while it did not co-IP with DFF40 or DFF45, which share homology with the N-term domain of CIDE proteins ([Figure 4C](#fig4){ref-type="fig"}). As BAT cells express high levels of both CIDEA and CIDEC, the formation of CIDE heterocomplexes could be involved in the regulation of LD enlargement to retain the multilocular state.

CIDEA interacts with phosphatidic acid {#s2-7}
--------------------------------------

To further characterize the interaction of CIDEA with the LD membrane, we utilized lipid strips to investigate the affinity of CIDEA for different lipids present in mammalian cell membranes and found that it selectively bound a set of anionic phospholipids ([Figure 5A](#fig5){ref-type="fig"}). The interaction with phosphatidic acid (PA) was of particular interest, as increased levels of this phospholipid have been linked with LD fusion ([@bib19]) and the identification of enzymes such as AGPAT3 and LIPIN-1γ in LDs supports the existence of in situ generation and consumption of PA ([@bib69]; [@bib66]). PA binding was confirmed by the strong affinity of CIDEA-v5 for PA beads ([Figure 5B](#fig5){ref-type="fig"}), which was greatly reduced by pre-incubation of the lysate with soluble PA, but not phosphatidylcholine (PC). Although the N-term fragment showed some residual affinity, the main PA-binding site of CIDEA was in the C-term region containing the amphipathic helix (163--180) ([Figure 5C](#fig5){ref-type="fig"}). The charge inversion of its three cationic amino acids resulted in the loss of affinity for PA beads in the inactive mutant (K167E/R171E/R175E)-CIDEA-v5 without affecting its LD localization ([Figure 5C](#fig5){ref-type="fig"}), linking PA binding with the TAG-transference step ([Figure 5D](#fig5){ref-type="fig"}).10.7554/eLife.07485.011Figure 5.CIDEA is a phosphatidic acid (PA)-binding protein.(****A****) Lipid strip assay showing the affinity of CIDEA-v5 for certain anionic phospholipids. (****B****) Interaction of CIDEA-v5 with PA beads. Binding was reduced by pre-incubation of the lysate with soluble PA, but not phosphatidylcholine (PC). (****C****) The affinity for PA beads was highly reduced in CIDEA-v5 constructs with alterations in its C-term hydrophobic and basic region (162--197). (****D****) CIDEA-(K167E/R171E/R175E)-v5 localizes to LDs and induces their clustering but cannot promote their enlargement by lipid transfer. Representative images are shown of experiments performed in a minimum of three independent experiments for every construct (n\>50 cells). (**E**) Circular dichroism spectra of the synthetic wild type (wt) or mutant (F166R/V169R/L170R) CIDEA peptides encompassing aas 158--185 solubilized in 25 mM sodium phosphate (pH 7.2) at concentrations of 70 μM (wt) and 47 μM (mutant). Peptide samples were prepared in the absence and presence of increasing amounts of DPLC or DLPC:DLPA (9:1 molar ratio). (****F--H****) Coarse-grained molecular dynamics (CG-MD) simulations of peptide interactions with LDs (PC: hydrophobic chains, transparent blue, polar heads, opaque blue; TAG: hydrophobic chains, dark brown, glycerol chain, light brown; PA: hydrophobic chains, transparent red, polar heads, opaque red; peptides: yellow, with cationic aa in blue and anionic in red). (****F****) Selected time points of the wt helix simulation with PC-LDs. At 124 ns the helix initiates the contact through its hydrophobic face, being rapidly embedded in the phospholipid monolayer. TAG molecules can abandon the neutral lipid core and are integrated in the hydrophobic region of the phospholipid monolayer. (****G****) Distance between the peptide and LD centre of mass (COM) versus time for the different helices with a PC-LD and a PC:PA-LD. The dashed line represents the approximate location of LD phospholipid head groups. (****H****) Different views of the configuration of the LD helix at the end of the simulations. Interaction between the polar head of PA and the helix can be observed for the wt and F166R/V169R/L170R but not K167E/R171E/R175E. (****I--K****) Comparison of full-length hCIDEC-v5 and the lipodystrophy-associated truncation hCIDEC-(E186X)-v5, including LD localization and morphology (****I****), co-IP with CIDEA-HA (****J****), and affinity for PA beads (****K****). Each co-IP, PA-binding assay, and lipid strip assay was performed at least in triplicate, producing similar results in each experiment.**DOI:** [http://dx.doi.org/10.7554/eLife.07485.011](10.7554/eLife.07485.011)10.7554/eLife.07485.012Figure 5---figure supplement 1.Secondary structure determination of CIDEA amino acids 158--185 (wild type and F166R/V169R/L170R) by CDPro DATABASE 4 (43 soluble proteins) using the CONTINLL program.**DOI:** [http://dx.doi.org/10.7554/eLife.07485.012](10.7554/eLife.07485.012)10.7554/eLife.07485.013Figure 5---figure supplement 2.Computational prediction of the amphipathic helix and LD interactions.CG-MD simulations of peptide interactions with LDs (PC: hydrophobic chains, transparent blue, polar heads, opaque blue; TAG: hydrophobic chains, dark brown, glycerol chain, light brown; PA: hydrophobic chains, transparent red, polar heads, opaque red; peptides: yellow, with cationic aa in blue and anionic in red). Selected time points of the wt helix and K167E/R171E/R175E helix simulation with PC-LDs or PC:PA-LDs are indicated.**DOI:** [http://dx.doi.org/10.7554/eLife.07485.013](10.7554/eLife.07485.013)10.7554/eLife.07485.014Figure 5---figure supplement 3.TAG infiltration into the phospholipid monolayer.(****A****) 2D number density maps of TAG molecules along the z direction from the CG-MD simulations. TAG frequency was measured over 76 ns before and after the docking of the wt helix to the membrane. The differential distribution before and after docking reveals an increase in the presence of TAG molecules in the membrane, which was revealed by the red spots in the outer arch and blue in the inner. (****B****) CG-MD simulations of peptide interactions with LDs (PC: hydrophobic chains, transparent blue, polar heads, opaque blue; TAG: hydrophobic chains, dark brown, glycerol chain, light brown; PA: hydrophobic chains, transparent red, polar heads, opaque red; peptides: yellow, with cationic aa in blue and anionic in red). Selected time points of the wt helix with PC-LD show TAG molecules in the LD membrane were increased after CIDEA peptide docking (170 vs 24 ns).**DOI:** [http://dx.doi.org/10.7554/eLife.07485.014](10.7554/eLife.07485.014)10.7554/eLife.07485.015Figure 5---figure supplement 4.Computational prediction of PA docking to the amphipathic helix structure of CIDEA.(****A****) Charge-smoothed potential of the predicted putative amphipathic helix of murine CIDEA (aas 163--180). Stick representation has been employed to highlight the positively charged residues K167, R171, and R175. (****B****) The nine top-ranked models from molecular docking of PA and the amphipathic helix using Autodock Vina. Interaction of the PA phosphate group with R171 and R175 is observed in eight of them, while the hydrophobic chains of the phospholipid can adopt multiple configurations.**DOI:** [http://dx.doi.org/10.7554/eLife.07485.015](10.7554/eLife.07485.015)

To investigate if PA affects the structure of the amphipathic helix, we repeated the CD analyses in phosphate buffer in the presence and absence of DLPC lipid vesicles with and without DLPA. Fitting of the CD data suggested a low (\~5%) helical content for the wt peptide when analysed in phosphate buffer alone, and indicated a predominantly sheet/coil structure in the absence of detergent or liposomes. The presence of DLPC liposomes stabilized a sharp increase in α-helical structure (up to 40%) and an equivalent reduction of sheet content ([Figure 5E](#fig5){ref-type="fig"} and [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}), yielding higher helical content than that observed in n-dodecyl-β-D-maltopyranoside micelles (\~25%, [Figure 3C](#fig3){ref-type="fig"}). In contrast, the induction of helix formation by DLPC was not observed in a mutant peptide carrying the substitutions impairing LD targeting in CIDEA-(F166R/V169R/L170R)-v5 ([Figure 5E](#fig5){ref-type="fig"}). This mutant peptide remained predominantly random coil in the absence and presence of DLPC liposomes. Interestingly, fitting of the CD data indicated significant helical content for both the wt and mutant peptides in the presence of DLPC:DLPA (9:1) vesicles ([Figure 5E](#fig5){ref-type="fig"} and [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). This indicates that the interaction with the negatively charged phospholipid PA can compensate for the excess of positive charges in CIDEA-(F166R/V169R/L170R)-v5.

To obtain more detailed insight into the interaction of the amphipathic helix with phospholipids and the role of PA in this process, the interaction of the amphipathic helix with LDs was modelled using coarse-grained molecular dynamics (CG-MD) simulations ([Figure 5F--H](#fig5){ref-type="fig"}). CG-MD simulations are well established for lipid-containing systems ([@bib45]), including LDs ([@bib48]), and have the advantage over full atomistic simulations in that the time scales required are much smaller allowing us to compare different LD compositions and helix mutants in the large multimolecular LD system. The wt (163--180) helix (CTSFKAVLRNLLRFMSYA) diffused towards the LD containing 400 palmitoyl-oleoyl-glycero-phosphocholine (POPC) and 200 TAG molecules where it interacted at its full length with the LD surface and penetrated into the hydrophobic region of the phospholipid monolayer covering the TAG core ([Figure 5F, G](#fig5){ref-type="fig"}). A similar behaviour was observed by the charge-inverted mutant K167E/R171E/R175E ([Figure 5G](#fig5){ref-type="fig"} and [Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}), supporting the experimental result that these mutations do not affect LD localization in CIDEA ([Figures 2C](#fig2){ref-type="fig"} and [3E](#fig3){ref-type="fig"}). In contrast, no interaction with the LD was observed with the non-amphipathic F166R/L169R/V169R ([Figure 5G](#fig5){ref-type="fig"}), which also impairs LD binding in CIDEA ([Figures 2C](#fig2){ref-type="fig"} and [3E](#fig3){ref-type="fig"}) and which was unable to attain stable secondary structure as evidenced by CD ([Figure 5E](#fig5){ref-type="fig"}). Similarly, a non-amphipathic α-helix in N-term (SSLQELISKTLDVLVITT) also showed no interaction with the LD ([Figure 5G](#fig5){ref-type="fig"}).

To study the effect of PA on LD structure and interaction with the CIDEA helix, we replaced 10% of the PC molecules with PA. The equilibration of the system resulted in a slight deformation of the spherical shape of the LD ([Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}). The wt helix made a stable complex with this LD at even earlier simulation times than with the PC-only containing LDs ([Figure 5G](#fig5){ref-type="fig"} and [Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}). The triple-E replacement mutant was also able to bind this LD, and even the F166R/L169R/V169R mutant was now able to interact with the membrane ([Figure 5G](#fig5){ref-type="fig"}). This result fits well with the CD results where the addition of PA also rescued the helix induction in this mutant peptide through interaction with the liposomes ([Figure 5E](#fig5){ref-type="fig"}). Interestingly, while the presence of PA permitted the accommodation of the F166R/L169R/V169R helix in the LD monolayer, it could not penetrate as deep towards the TAG core as the wt or helix. The average distance of the peptide to the centre of the LD ( ± SEM) was 5.6 ± 0.04 nm and 5.7 ± 0.03 nm for wt and K167E/R171E/R175E, respectively. In the presence of PA, the distance was 5.6 ± 0.02 nm, 5.7 ± 0.02 nm, and 6.1 ± 0.02 for wt, K167E/R171E/R175E, and F166R/L169R/V169R, respectively (also see [Figure 5G, H](#fig5){ref-type="fig"}). This result confirms that the presence of the hydrophobic face was necessary for proper helix insertion in the LD monolayer.

The CG-MD simulations not only shed light on the interaction between the helix and the LD, but also provided an indication of the mechanism by which this process could lead to LD enlargement by TAG transference. We observed that TAG molecules were able to escape the LD core and were integrated in the hydrophobic section of the membrane ([Figure 5H](#fig5){ref-type="fig"}). This TAG infiltration was increased after the docking of the wt helix in the membrane ([Figure 5---figure supplement 3](#fig5s3){ref-type="fig"}), suggesting that CIDEA could promote the migration of TAG into the membrane as an intermediate state prior to the transference to the acceptor LD. To complete the transference, the hydrophobic TAG molecules should overcome the energy barrier constituted by the phospholipid polar heads and water molecules in the LD--LD interface. Interestingly, we observed that the wt helix could attract PA molecules in its vicinity by the interaction of its cationic residues with the negatively charged polar head of PA ([Figure 5H](#fig5){ref-type="fig"}). A direct interaction of the amphipathic helix with PA was also indicated by molecular docking using Autodock Vina, which supported the role of the K167, R171, and R175 residues in the interaction ([Figure 5---figure supplement 4](#fig5s4){ref-type="fig"}). Remarkably, CG-MD simulations showed that whereas the non-amphipathic cationic helix F166R/L169R/V169R also interacted with PA molecules from its superficial docking position in the LD membrane, the anionic amphipathic mutant K167E/R171E/R175E was docked in a PA-depleted area and avoided the PA molecules ([Figure 5H](#fig5){ref-type="fig"}). Although TAG infiltration was also observed in this simulation and the helix was well embedded in the membrane, its inability to attract PA molecules could be responsible for the lack of TAG transference activity in CIDEA-(K167E/R171E/R175)-v5 ([Figure 5D](#fig5){ref-type="fig"}). Taken together, these results indicate that CIDEA binds the LD by embedding a cationic amphipathic helix into the LD monolayer and that once there, it can interact with PA molecules, which could facilitate TAG transference.

We found that PA binding was a feature common to all three members of the CIDE protein family ([Figure 5C](#fig5){ref-type="fig"}). Intriguingly, we determined that an inactive CIDEC identified in a patient with lipodystrophy ([@bib57]) contained a truncation (E186X) in the predicted PA-binding site. Although hCIDEC-(E186X)-v5 and the equivalent mCIDEA-(N172X)-v5 were localized in LDs in a high percentage of cells, they were completely unable to induce LD enlargement ([Figures 2C](#fig2){ref-type="fig"} and [5I](#fig5){ref-type="fig"}). LD clustering activity and its ability to interact with CIDE proteins was not altered in hCIDEC-(E186X)-v5 ([Figure 5I, J](#fig5){ref-type="fig"}), but it showed no affinity for PA ([Figure 5K](#fig5){ref-type="fig"}). Thus, PA binding could be involved in the lipid transfer phase of CIDE activity.

PA is required for LD enlargement {#s2-8}
---------------------------------

To confirm the requirement of PA binding, we examined the effect of PA depletion on CIDEA activity. While substantial alterations in the phospholipid composition of mammalian cells often compromise their viability, yeast cells offer a wide range of genetically modified strains with well-characterized alterations in phospholipid metabolism ([Figure 6A](#fig6){ref-type="fig"}) ([@bib30]). Thus, despite the absence of CIDE homologues in yeast ([@bib70]), we explored the functionality of CIDEA in wt and genetically modified strains of *Saccharomyces cerevisiae* ([Figure 6---source data 1](#SD1-data){ref-type="supplementary-material"}).10.7554/eLife.07485.016Figure 6.CIDEA is functional in yeast and requires PA.(****A****) Pathway showing the reactions catalyzed by the enzymes altered in the studied yeast strains. (****B****) Stable expression of mCIDEA-v5 in three transformed yeast clones. (****C****) Frequency distribution of the diameter of the largest LD per cell. (****D****) LD staining in the studied yeast strains transformed with pRS316-CYC1p-Cidea or the empty vector. (**E, F**) Quantification of LD size and number per cell in randomly acquired images (100--200 cells/condition). CIDEA activity in yeast was measured by its ability to increase the percentage of cells with supersized LDs (****E****) and reduce the total number of LDs per cell (****F****). (**G, H**) Effect of CIDEA and *PAH1*-7A expression in the cellular levels of PA (****G****) and its synthesis rate (****H****). Three different yeast clones per condition were analysed, and results are shown as the mean ± SEM. One-way ANOVA with Bonferroni post-test was performed to determine significant differences due to the presence of CIDEA (\**p*\<0.05; \*\*\**p*\<0.001). (****I--L****) Coexpression of hLIPIN-1γ-v5 and CIDEA-HA in Hela cells. (****I****) Representative immunofluorescence images showing LD staining (blue) in Hela cells expressing CIDEA-HA (green) in the presence or absence of hLIPIN-1γ-v5 (red). Twenty-four hours after overexpression of hLIPIN-1γ-v5, cells were transfected with pcDNA3.1/Cidea-HA and incubated for a further 24 hr. (****J****) Phenotypic distribution in randomly selected cells (n\>50) showing the average values for three independent experiments. (****K****) Co-IP assay in lysates of transfected Hela cells. (****L****) PA beads binding assay for hLIPIN-1γ-v5. Each co-IP and PA-binding assay was performed at least in triplicate, producing similar results in each experiment.**DOI:** [http://dx.doi.org/10.7554/eLife.07485.016](10.7554/eLife.07485.016)10.7554/eLife.07485.017Figure 6---source data 1.List of yeast strains used in this study.**DOI:** [http://dx.doi.org/10.7554/eLife.07485.017](10.7554/eLife.07485.017)

Murine CIDEA could be stably expressed in yeast cells ([Figure 6B](#fig6){ref-type="fig"}), producing an increase in the size of their LDs ([Figure 6C](#fig6){ref-type="fig"}). Yeast cells expressing wt CIDEA, but not the inactive R171E/R175E mutant, contained fewer and larger LDs than the control ([Figure 6D--F](#fig6){ref-type="fig"}), indicating that murine CIDEA was functional in these cells. By measuring the frequency of supersized LDs (diameter above 0.5 μm) and the total number of LDs in strains with altered lipid metabolism, we could determine the yeast strains in which CIDEA was able to induce LD enlargement ([Figure 6E, F](#fig6){ref-type="fig"}). CIDEA was inactive in cells defective in phospholipase D (pld1△) ([@bib55]), which catalyzes the production of PA from PC. CIDEA activity was also abrogated in cells expressing a hyperactive form of the PA phosphohydrolase (PAH1-7A) ([@bib12]; [@bib13]). These results indicate that PA is necessary for CIDEA activity. In addition, we observed that total cellular PA levels were increased by CIDEA, an effect that was prevented by the expression of *PAH1-7A* ([Figure 6G](#fig6){ref-type="fig"}). As the PA synthesis rate was not affected ([Figure 6H](#fig6){ref-type="fig"}), CIDEA could be protecting a pool of PA from degradation.

The deletion of diacylglycerol kinase (*dgk1*△) ([@bib26]) did not affect CIDEA activity. *DGK1* is important for the generation of phospholipids from TAG as cells exit from stasis ([@bib17]), but its deletion has not been shown to have a great effect on PA levels under normal growth conditions. Regarding *PAH1*, its deletion produces dramatic cellular effects ([@bib59]), including defective LD formation ([@bib1]; [@bib18]). As this alteration in LDs can be compensated by the deletion of *DGK1*, we chose to use the *dgk1*△*pah1*△ strain, observing normal LD enlargement by CIDEA ([Figure 6E, F](#fig6){ref-type="fig"}). CIDEA was also able to further increase the LD size in the *cho2*△ strain, which lacks the phosphatidylethanolamine (PE) methylation pathway for PC synthesis, and has been shown to present supersized LDs and high levels of PA and PE ([@bib19]). The CIDEA-induced LD enlargement in yeast was not due to a mere coating effect protecting LDs against lipases, as it was functional in the *tgl3*△*tgl4*△*tgl5*△ strain, which lacks lipase activity. As expected, CIDEA could not induce the appearance of LDs in *dga1*△*lro1*△*are1*△*are2*△ cells ([Figure 6D](#fig6){ref-type="fig"}), which are deficient in the enzymes required for TAG and steryl ester synthesis and contain no LDs ([@bib58]).

To study the role of PA-dependent CIDEA action in mammalian cells without compromising other PA-dependent cellular processes, we specifically degraded this phospholipid in LDs by overexpressing a LD-localized isoform of PA phosphohydrolase (LIPIN-1γ) ([@bib66]; [@bib27]). While CIDEA-HA displayed normal activity in cells co-transfected with an empty vector, it was unable to promote LD enlargement in cells expressing LIPIN-1γ-v5 ([Figure 6I, J](#fig6){ref-type="fig"}). LIPIN-1γ-v5 showed affinity for PA but it did not co-IP with CIDEA, indicating that its inhibitory effects were not due to a direct interaction between these proteins ([Figure 6K, L](#fig6){ref-type="fig"}). Taken together, these results reveal that the mechanism of action of CIDEA involves direct interaction with PA molecules in the LD monolayer.

Discussion {#s3}
==========

The Cidea gene is highly expressed in BAT, induced in WAT following cold exposure ([@bib56]), and is widely used by researchers as a defining marker to discriminate brown or brite adipocytes from white adipocytes ([@bib29]; [@bib74]). As evidence indicated a key role in the LD biology ([@bib25]), we have characterized the mechanism by which CIDEA promotes LD enlargement, which involves the targeting of LDs, the docking of LD pairs, and the transference of lipids between them. The lipid transfer step requires the interaction of CIDEA and PA through a cationic amphipathic helix. Independently of PA binding, this helix is also responsible for anchoring CIDEA in the LD membrane. Finally, we demonstrate that the docking of LD pairs is driven by the formation of CIDEA complexes involving the N-term domain and a C-term interaction site.

CIDE proteins appeared during vertebrate evolution by the combination of an ancestor N-term domain and a LD-binding C-term domain ([@bib70]). In spite of this, the full process of LD enlargement can be induced in yeast by the sole exogenous expression of CIDEA, indicating that in contrast to SNARE-triggered vesicle fusion, LD fusion by lipid transference does not require the coordination of multiple specific proteins ([@bib54]). While vesicle fusion implies an intricate restructuring of the phospholipid bilayers, LD fusion is a spontaneous process that the cell has to prevent by tightly controlling their phospholipid composition ([@bib37]). However, although phospholipid-modifying enzymes have been linked with the biogenesis of LDs ([@bib24]; [@bib2]), the implication of phospholipids in physiologic LD fusion processes has not been previously described.

Complete LD fusion by lipid transfer can last several hours, during which the participating LDs remain in contact. Our results indicate that both the N-term domain and a C-term dimerization site (aa 126--155) independently participate in the docking of LD pairs by forming trans interactions ([Figure 7](#fig7){ref-type="fig"}). Certain mutations in the dimerization sites that do not eliminate the interaction result in a decrease of the TAG transference efficiency, reflected by the presence of small LDs docked to enlarged LDs. This suggests that in addition to stabilizing the LD--LD interaction, the correct conformation of the CIDEA complexes is necessary for optimal TAG transfer. Furthermore, the formation of stable LD pairs is not sufficient to trigger LD fusion by lipid transfer. In fact, although LDs can be tightly packed in cultured adipocytes, no TAG transference across neighbour LDs is observed in the absence of CIDE proteins ([@bib21]), showing that the phospholipid monolayer acts as a barrier impermeable to TAG. Our CG-MD simulations indicate that certain TAG molecules can escape the neutral lipid core of the LD and be integrated within the aliphatic chains of the phospholipid monolayer. This could be a transition state prior to the TAG transference, and our data indicate that the docking of the amphipathic helix in the LD membrane could facilitate this process. However, the infiltrated TAGs in LD membranes in the presence of mutant helices, or even in the absence of docking, suggests that this is not enough to complete the TAG transference.10.7554/eLife.07485.018Figure 7.Proposed molecular mechanism.(****A****) CIDEA targets the LD through its C-term amphipathic helix and once diffused to the LD surface, it forms cis CIDEA complexes by interacting through the C-term (126--155) region. When two CIDEA-containing LDs make contact, trans interactions between CIDEA molecules in each droplet can be established, which will facilitate the docking of the LDs. Both the N-term and the C-term would contribute by dimerizing with their counterparts of the neighbour LD. This trans interaction will anchor the CIDEA complexes in the LD--LD contact site, promoting a local enrichment of CIDEA. The monolayers of the two LDs will be maintained at short distance by the CIDEA complex. The amphipathic helices, embedded in the hydrophobic region of the membrane, will interact with the cone-shaped PA, creating a local perturbation in the phospholipid barrier that will increase its permeability to TAG. (****B****) The docking of the amphipathic helix to the membrane could facilitate the integration of TAG molecules within the phospholipid hydrophobic tails. Although the helix will be stabilized with its cationic residues pointing outwards, it will interact with PA molecules in its vicinity, which could be pulled out of the monolayer by the helix molecular dynamics. This could create a transitory discontinuity in the polar barrier that will reduce the energy required to transfer the TAG molecules present in the membrane. This alteration, together with the microenvironment created by the CIDEA complex, will reduce the energy barrier necessary to transfer TAG molecules between LDs, allowing the LD growth by lipid transference.**DOI:** [http://dx.doi.org/10.7554/eLife.07485.018](10.7554/eLife.07485.018)

To be transferred to the adjacent LD, the TAGs integrated in the hydrophobic region of the LD membrane should cross the energy barrier defined by the phospholipid polar heads, and the interaction of CIDEA with PA could play a role in this process, as suggested by the disruption of LD enlargement by the mutations preventing PA binding (K167E/R171E/R175E) and the inhibition of CIDEA after PA depletion. The minor effects observed with more conservative substitutions in the helix suggest that the presence of positive charges is sufficient to induce TAG transference by attracting anionic phospholipids present in the LD membrane. PA, whose requirement is indicated by our PA-depletion experiments, is a cone-shaped anionic phospholipid that could locally destabilize the LD monolayer by favouring a negative membrane curvature that is incompatible with the spherical LD morphology ([@bib36]). Interestingly, while the zwitterion PC, the main component of the monolayer, stabilizes the LD structure ([@bib37]), the negatively charged PA promotes their coalescence ([@bib19]). This is supported by our CG-MD results which resulted in a deformation of the LD shape by the addition of PA. We propose a model in which the C-term amphipathic helix positions itself in the LD monolayer and interacts with PA molecules in its vicinity, which might include trans interactions with PA in the adjacent LD. The interaction with PA disturbs the integrity of the phospholipid barrier at the LD--LD interface, allowing the LD to LD transference of TAG molecules integrated in the LD membrane ([Figure 7](#fig7){ref-type="fig"}). Additional alterations in the LD composition could facilitate TAG transference, as differentiating adipocytes experience a reduction in saturated fatty acids in the LD phospholipids ([@bib3]), and in their PC/PE ratio ([@bib33]), which could increase the permeability of the LD membranes; we previously observed that a change in the molecular structures of TAG results in an altered migration pattern to the LD surface ([@bib48]).

During LD fusion by lipid transfer, the pressure gradient experienced by LDs favours TAG flux from small to large LDs ([@bib21]). However, the implication of PA, a minor component of the LD membrane, could represent a control mechanism, as it is plausible that the cell could actively influence the TAG flux direction by differently regulating the levels of PA in large and small LDs, which could be controlled by the activity of enzymes such as AGPAT3 and LIPIN-1γ ([@bib69]; [@bib66]). This is a remarkable possibility, as a switch in the favoured TAG flux direction could promote the acquisition of a multilocular phenotype and facilitate the browning of WAT ([@bib5]). Interestingly, Cidea mRNA is the LD protein-encoding transcript that experiences the greatest increase during the cold-induced process by which multilocular BAT-like cells appear in WAT ([@bib5]). Furthermore, in BAT, cold exposure instigates a profound increase in CIDEA protein levels that is independent of transcriptional regulation ([@bib73]). The profound increase in CIDEA is coincident with elevated lipolysis and de novo lipogenesis that occurs in both brown and white adipose tissues after β-adrenergic receptor activation ([@bib50]). It is likely that CIDEA has a central role in coupling these processes to package newly synthesized TAG in LDs for subsequent lipolysis and fatty acid oxidation. Importantly, BAT displays high levels of glycerol kinase activity ([@bib7]; [@bib8]) that facilitates glycerol recycling rather than release into the blood stream, following induction of lipolysis ([@bib51]), which occurs in WAT. Hence, the reported elevated glycerol released from cells depleted of CIDEA ([@bib74]) is likely to be a result of decoupling lipolysis from the ability to efficiently store the products of lipogenesis in LDs, therefore producing a net increase in detected extracellular glycerol. This important role of CIDEA is supported by the marked depletion of TAG in the BAT of Cidea-null mice following overnight exposure to a temperature of 4°C ([@bib74]) and by our finding that CIDEA-dependent LD enlargement is maintained in a lipase-negative yeast strain.

Cidea and the genes that are required to facilitate high rates of lipolysis and lipogenesis are associated with the \'browning\' of white fat either following cold exposure ([@bib56]) or in genetic models such as RIP140 knockout WAT ([@bib35]). The induction of a brown-like phenotype in WAT has potential benefits in the treatment and prevention of metabolic disorders ([@bib68]). Differences in the activity and regulation of CIDEC and CIDEA could also be responsible for the adoption of unilocular or multilocular phenotypes. In addition to their differential interaction with PLIN1 and 5, we have observed that CIDEC is more resilient to the deletion of the N-term than CIDEA, indicating that it may be less sensitive to regulatory post-translational modifications of this domain. This robustness of CIDEC activity together with its potentiation by PLIN1 could facilitate the continuity of the LD enlargement in white adipocytes until the unilocular phenotype is achieved. In contrast, in brown adipocytes expressing CIDEA the process would be stopped at the multilocular stage, for example, due to post-translational modifications that modulate the function or stability of the protein or alteration of the PA levels in LDs.

Further work will be required to characterize the physiological differences between CIDEC and CIDEA, and determine the influence of their interacting partners and the role of proteins that are able to alter the LD PA levels, such as Lipin-1γ. Abnormal accumulation of large LDs have also been observed in non-adipocyte cells under other pathological conditions such as liver steatosis and atherosclerosis ([@bib38]). As enhanced expression of CIDE proteins have been linked to these conditions ([@bib41]; [@bib75]; [@bib46]), the modulation of CIDE-triggered LD enlargement represents a potential therapeutic strategy that requires the elucidation of its molecular mechanism.

In summary, we found that during LD fusion by lipid transference, CIDEA ensures the close proximity of the LD membranes by forming trans complexes through its N-term and C-term dimerization sites. This protein complex will be anchored in the LD--LD interface, forming the molecular environment necessary for TAG transport across the membrane. Finally, the amphipathic helix embedded in the LD membrane interacts with the cone-shaped phospholipid PA, generating a local perturbation of the monolayer integrity that would increase its permeability to TAG and enable its exportation to the acceptor LD. The new mechanistic insight into the molecular events underpinning LD dynamics revealed by this study highlights CIDEA and PA production as targets for therapeutic modulation of LD accumulation.

Materials and methods {#s4}
=====================

Plasmids and antibodies {#s4-1}
-----------------------

The coding region of murine Cidea, Cideb, Cidec, Dff40, and Dff45 were cloned into the vector pcDNA3.1D/V5-His-TOPO (Invitrogen, Paisley, UK) to obtain the v5-tagged versions of the proteins ([@bib25]). The human full-length and truncated forms of Cidec were subcloned into pcDNA3.1D/V5-His-TOPO from their GFP constructs ([@bib57]) and Lipin-1γ-v5 was constructed from pGH321 ([@bib27]). Mutations and deletions were generated with the QuikChange Lightning Kit (Agilent). Tagged proteins were detected by using antibodies against v5 (R96025; Invitrogen), HA (H6908; Sigma), or GFP (ab1218; Abcam).

Cell culture and transfection {#s4-2}
-----------------------------

3T3-L1 cells were maintained in Dulbecco's modified Eagle's medium (DMEM) containing 4.5 g/l glucose and L-glutamine supplemented with 10% newborn calf serum (NCS; Invitrogen) and penicillin/streptomycin at 37°C and 5% CO~2~. Hela cells were cultured in similar conditions but with 10% FBS (Invitrogen). Transfections were performed using Lipofectamine 2000 (Invitrogen). Stable cell lines expressing CIDEA-v5 were generated by transfection of 3T3-L1 cells with pcDNA3.1/Cidea-v5, followed by selection with G418 (Invitrogen). The imBAT cell line was generated by the retroviral transduction of primary brown adipocytes with SV40 large-T antigen tsA58 mutant and differentiated as previously described ([@bib25]).

4D live cell imaging {#s4-3}
--------------------

Cells in gelatin-coated glass bottom dishes were stained with 0.1--0.5 μg/ml BODIPY 493/503 in the appropriate culture medium with 20 mM HEPES in the absence of serum. After 10 min at 37°C, 10% FBS was restored and the dish was equilibrated at 37°C in a Leica SP5 confocal microscope. Time-lapse Z-stacks were acquired every 2 min and represented as their maximum projection. 3T3-L1 cells were analysed 6 hr after infection with an adenovirus vector expressing CIDEA ([@bib25]). For the imBAT differentiation experiments, pre-adipocytes were incubated for 48 hr with differentiation cocktail ([@bib25]), and medium was changed to DMEM:F12 with 10% FBS, 1nM T3, and 170 nM insulin for 6 hr before staining.

Immunofluorescence {#s4-4}
------------------

Cells on glass coverslips were fixed in 4% paraformaldehyde and permeabilized with blocking solution (BS: 0.5% BSA, 0.05% Saponin, 50 mM NH~4~Cl in PBS). Cells were incubated overnight at 4°C with primary antibodies diluted in BS, and for 1 hr at room temperature with secondary antibodies (conjugated to Alexa488 and Alexa555, Invitrogen). Cells were stained in PBS with 2 μg/ml BODIPY 493/503 or 1:200 dilution of LipidTox Deep Red for 15 min and mounted in ProLong Gold antifade reagent (all from Invitrogen). Images were acquired in a Leica TCS SP5 microscope. For the phenotypic distribution of Hela cells expressing modified CIDEA-v5 constructs, cells were treated with oleic acid 24 hr after transfection and incubated for a further 18 hr prior to fixation. Phenotype classification was performed by visual analysis of randomized samples in a minimum of three independent experiments for each construct (n\>50 cells)

Liposome preparation {#s4-5}
--------------------

Liposomes were prepared by dissolving lipid (1,2-dilauroyl-sn-glycero-3-phosphocholine (DLPC), 12:0 PC) or a mixture of DLPC and DLPA (1,2-dilauroyl-sn-glycero-3-phosphate, 12:0 PA; at a 9:1 DLPC:DLPA molar ratio) (Echelon Biosciences, USA) in 3:1 chloroform:MeOH and drying under vacuum using rotary evaporation. The resulting thin films were left to dry under vacuum overnight to remove all residual solvent, reconstituted in 25 mM sodium phosphate buffer (pH 7.2) to a final lipid concentration of 3.3 mg/mL, and subjected to four times freeze-thaw-sonicate cycles. The vesicles were incubated at 37°C for 20 min prior to CD measurements.

Circular dichroism {#s4-6}
------------------

CD experiments were undertaken with a synthetic wt (SYDIRCTSFKAVLRNLLRFMSYAAQMTG) CIDEA peptide (Pepmic, Suzhou, China) encompassing aas 158--185 solubilized at a concentration of 41 μM (based on absorbance at 280 nm) in 50 mM potassium phosphate, pH 6.2 plus 0.1% n-dodecyl-β-D-maltopyranoside and analysed by CD in a Jasco J-815 spectrometer (Jasco UK, Great Dunmow, UK).

Additional CD experiments with the same wt peptide and a mutant (F166R/V169R/L170R) (SYDIRCTSRKARRRNLLRFMSYAAQMTG) were carried out using a Jasco J-1500 spectropolarimeter (Jasco UK) equipped with a Peltier thermally controlled cuvette holder and 1 mm path-length quartz cuvettes (Starna; Optiglass, Hainault, UK). Spectra were recorded between 190 and 300 nm with a data pitch of 0.2 nm, a bandwidth of 2 nm, a scanning speed of 100 nm min^--1^ and a response time of 1 second. Peptides were solubilized in 25 mM sodium phosphate (pH 7.2) at concentrations of 70 μM (wt) and 47 μM (mutant). Peptide samples were prepared in the absence and presence of DPLC and DLPC:DLPA (9:1 molar ratio) vesicles and CD spectra were acquired at 37°C. Data shown were averaged from four individual spectra after subtraction of the appropriate buffer/vesicle CD spectrum. All CD data were analysed using the CDPro suite of programs. The output of the individual programs CDSSTR and CONTINLL provided the estimated percentages of α-helix, β-sheet, turn, and unstructured regions, using the IB = 4 database of 43 soluble proteins with CD data from 190--250 nm.

Structure prediction and molecular docking {#s4-7}
------------------------------------------

Secondary structure propensity of full-length CIDEA was predicted using DSSP ([@bib4]). The amphipathic helix sequence CTSFKAVLRNLLRFMSYA (163--180 aa) was submitted to the PEP-FOLD online de novo peptide structure prediction server using default settings ([@bib47]). PA was docked to the PEP-FOLD predicted structure using default settings in a single simulation by AutoDock Vina53 (<http://vina.scripps.edu>) ([@bib62]). Lipid and protein structures were converted from pdb into pdbqt format using MGL Tools54. A grid box was centred at coordinates 35.651, 35.471, 35.569 with 34 Å units in x, y, and z directions to cover the entire helix. AutoDock Vina reports the nine lowest energy conformations, which were inspected using PyMOL software ([www.pymol.org](www.pymol.org)). According to binding affinity and visual inspection, without RMSD clustering, the best-fit model has been selected.

CG-MD simulations {#s4-8}
-----------------

CG-MD simulations were used to predict the structure of a LD and its putative interaction with the amphipathic helix using a 4 to 1 atom mapping for both, lipids and protein ([@bib45]; [@bib49]). A LD composed of a hydrophobic core containing 200 glyceryl trioleate or TAG molecules surrounded by a phospholipid monolayer containing 400 POPC molecules previously reported was used as the starting configuration ([@bib48]). A second LD containing PA consisting of a hydrophobic core of 200 TAG molecules, and a phospholipid monolayer with 364 POPC molecules and 36 palmitoyl-oleoyl-glycero-phosphatidic acid (POPA) was compiled using the same procedure. A rectangular simulation box including LD, amphipathic helix, water, and ions was energy minimized and pre-equilibrated. All MD runs were carried out for 200 ns under NPT conditions. The CG-MD simulation of the LD--helix interaction was carried out using the MARTINI CG force field developed by Marrink et al. (version 2.0) ([@bib45]). All simulations were performed using the GROMACS simulation package version 4.6.5 (<http://www.gromacs.org/>). The system was weakly coupled to an external temperature bath at 310 K ([@bib6]). The pressure was weakly coupled to an external bath at 1 bar using an isotropic pressure scheme ([@bib6]). Visualization and analysis was performed using the VMD v.1.9 visualization software ([@bib32]). Distances and density maps were computed using analysis tools (g_dist and g_densmap) in the GROMACS package (<http://www.gromacs.org>) ([@bib63]).

Immunoprecipitation {#s4-9}
-------------------

Cells were lysed in 50 mM Tris (pH 8.0), 150 mM NaCl, 1% TRITON X-100 with protease inhibitor cocktail (Roche). Anti-HA antibody (H6908; Sigma) or anti-V5 antibody (R96025; Invitrogen) was bound to Dynabeads Protein G (Invitrogen) and incubated with the lysate to immunoprecipitate the tagged proteins following manufacturer's instructions. Cell lysates or IP fractions in Laemmli buffer were analysed by Western blot. Each co-IP experiment was performed at least in triplicate, producing similar results in each experiment with a representative image presented.

Lipid binding assays {#s4-10}
--------------------

In vitro translated CIDEA-v5 was synthesized from pcDNA3.1/Cidea-v5 using the TnT Coupled Wheat Germ Extract System (Promega) and verified by Western blot. The cell-free preparation of CIDEA-v5 was probed with Membrane Lipid Strips (Echelon Biosciences) following the manufacturer's instructions. Protein affinity for PA was examined in pull-down assays using PA covalently linked to agarose beads (PA beads) ([@bib44]). Cells were lysed in 50 mM Tris-HCl pH 8.0, 50 mM KCl, 10 mM EDTA, 0.5% Nonidet P-40, and protease inhibitors. Lysates were sonicated and centrifuged at 14000*g* prior to incubation with the PA beads as previously described ([@bib44]). Competition experiments with soluble phospholipids were performed by supplementing the cell lysate with 1,2-dilauroyl-sn-glycero-3-phosphate 12:0 PC (DLPA) or 1,2-dilauroyl-sn-glycero-3-phosphocholine (DLPC) (Echelon Biosciences). Each PA-binding experiment was performed at least in triplicate, producing similar results in each experiment with a representative image presented.

CIDEA expression in yeast {#s4-11}
-------------------------

The *S. cerevisiae* strains used in this study are listed in Supplementary file 1. To express CIDEA in yeast, a codon-optimized version of the mouse Cidea gene was generated by artificial gene synthesis (GeneOracle), and subcloned into pRS316-CYC1p. Wt BY4742 ([@bib10]) and genetically modified yeast strains were transformed with pRS316-CYC1p-Cidea and stable transformants were selected in synthetic media minus uracil. Leucine selection was used for the expression of PAH1-7A with pHC204 ([@bib12]).

Microscopy analysis of yeast lipid droplets and image processing {#s4-12}
----------------------------------------------------------------

Yeast cells in synthetic media cultured overnight at 30°C were diluted to OD600 = 0.1 and allowed to grow until mid-logarithmic phase (OD600 = 0.5) before fixation with 4% formaldehyde and LD staining with 2 μg/ml BODIPY 493/503. For the automatic quantification of LDs, random microscopy images were acquired using a Delta Vision RT system (Applied Precision). Maximum intensity and integrated intensity projections were created from the deconvolved image stacks using ImageJ. A custom written CellProfiler pipeline ([@bib11]) automatically identified individual yeast cells and measured their number and size of circle shaped LDs. Supersized LDs were defined as the LDs with a diameter above 0.5 μm.

Steady state and pulse labelling of phospholipids {#s4-13}
-------------------------------------------------

To measure the total levels of phospholipids in yeast, cells were grown overnight in synthetic medium at 30°C in the presence of 20 μCi/mL \[^32^P\]-orthophosphate. Cultures were then diluted to OD600 = 0.1 maintaining the label and were allowed to grow until OD600 = 0.5. To analyse *de novo* synthesis of glycerophospholipids, cells were grown to OD600 = 0.5 in synthetic medium and incubated with 100 μCi/mL \[^32^P\]-for 20 min. Lipids were extracted and quantified by two-dimensional chromatography, as described by ([@bib20]).
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eLife posts the editorial decision letter and author response on a selection of the published articles (subject to the approval of the authors). An edited version of the letter sent to the authors after peer review is shown, indicating the substantive concerns or comments; minor concerns are not usually shown. Reviewers have the opportunity to discuss the decision before the letter is sent (see [review process](http://elifesciences.org/review-process)). Similarly, the author response typically shows only responses to the major concerns raised by the reviewers.

Thank you for sending your work entitled \"The brown adipocyte protein CIDEA promotes lipid droplet fusion via a phosphatidic acid-binding amphipathic helix\" for consideration at *eLife*. Your article has been favorably evaluated by Vivek Malhotra (Senior editor) and three reviewers, one of whom is a member of our Board of Reviewing Editors. All the reviewers were experts in lipid-binding proteins, and two were experts in the structural biology of protein-lipid interactions.

All three reviewers thought that this manuscript was interesting and that it contained novel and important information governing the biology of lipid droplets in adipocytes. The authors propose that the growth of lipid droplets involves the binding of an amphipathic helix in CIDEA to phosphatidic acid (PA), and that LD pairs are docked by CIDEA trans complexes through contributions of the N-terminal domain and a C-terminal dimerization region. All three reviewers had substantial concerns about the function of the amphipathic helix in CIDEA. Their concerns are listed below and should be addressed. Specifically:

1\) The authors should provide more information regarding the function of this domain, particularly the specificity of the interaction with phosphatidic acid. Many criticisms center on this issue.

2\) The reviewers were uncertain about the validity of the experimental systems that were used in this paper. All three reviewers wanted to see experiments that would directly assess the binding of the amphipathic helix (as well as mutant amphipathic helices) to a lipid monolayer at an aqueous interface. The authors should either use liposomes of defined composition or use a variety of oil-water interface systems that have been used to study the biophysical properties of amphipathic helices in other proteins, for example plasma apolipoproteins. These additional studies are important.

3\) The manuscript has a very large amount of information, reflecting considerable work. Many of the figures are impressive. However, it would be helpful to specify how many times each experiment was repeated.

4\) Also, with respect to the western blots, most of them showed only \"cut-out\" bands, and it was not clear whether those bands were taken from the same experiment and the same western blot. Please clarify. And if the bands were taken from different experiments, please discuss how the studies were interpreted.

5\) Also, as noted by the reviewers, several of the experiments contained an insufficient number of controls.

Reviewer 1:

CIDEA is a lipid droplet (LD)-protein enriched in brown adipocytes promoting the enlargement of LDs which are dynamic, ubiquitous organelles specialized for storing neutral lipids. The authors propose that this process involves phosphatidic acid (PA) binding to an amphipathic helix in CIDEA, and that LD pairs are docked by CIDEA trans complexes through contributions of the N-terminal domain and a C-terminal dimerization region.

Overall, this is an excellent to outstanding paper, which reveals new mechanisms in the formation of lipid droplets in adipocytes. The notion that the CIDEA amphipathic helix interacts avidly and specifically to phosphatidic acid is critical for this paper. I believe that the authors should make an attempt to document that the binding of CIDEA to a phospholipid-water interface (with or without triolein) interface and document changes in surface pressure, with the goal of documenting the specificity of the interaction with PA.

Some of the experiments need additional controls. For example, I would like the authors to better document the CD spectra of the mutant helix containing the Glu mutations. How about showing data for the mutant helix in [Figures 2F and 2G](#fig2){ref-type="fig"}?

Also, this reviewer would like to know more information about the specificity of the amphipathic helix interactions with PA. Would the interaction occur if the Arg residues were replaced with Lys or His, and if the Lys residue were replaced with Arg or His? Please report the conservation of all residues within the helix in vertebrate evolution.

Much of the data in the paper appears to be bands cut out of a western. Were all of these experiments performed on the same gel, or multiple gels? If the latter, please explain the controls for each experiment.

In [Figure 4B](#fig4){ref-type="fig"}, it would be nice to show additional controls with other anionic phospholipids bound to beads -- and examine competition with other anionic phospholipids. Also, testing the CIDEA mutant with the Glu mutations would be helpful. Similarly, [Figure 4I](#fig4){ref-type="fig"} and [Figure 5L](#fig5){ref-type="fig"} need additional controls.

Reviewer 2:

An important question that had remained open in research on CIDEA concerned the mechanistic on how CIDEA is involved in a hypothesized deformation of the monolayer of phospholipids, which surround the neutral lipid core of LD, and therefore might facilitate the transfer of neutral lipids.

Barneda et al. could identify mutants in the N-terminal half of the N-terminal domain to result in high percentages of large clustered LD with inefficient TAG transfer. The CIDE-N domain also appears to be involved in LD-LD docking since entire deletion of this domain or large parts of it yield mainly small, isolated lipid droplets). Additionally they identified an amphiphatic helix in the C-terminal half which leads to small, yet highly clustered LD indicating a defect in transfer of neutral lipids. The authors attribute this\' LD phenotype\' to impaired PA binding.

General comments:

Figure 1--figure supplement 1 is a central figure and should be included in the main text.

Introduction and subsection "A cationic amphipathic helix in C-term drives LD targeting": I would appreciate a more conservative approach in separating previously existing knowledge from new findings presented in this manuscript (e.g. of 3D structures or LD binding regions).

Subheading "A cationic amphipathic helix in C-term drives LD targeting" and [Figure 2](#fig2){ref-type="fig"}: According to the hypothesis put forward by the authors, the short sequence 162-197 should target the N-terminal domain fused to the LD targeting helix to the LD. This should be shown experimentally and would strongly enhance the sole importance of this helix as targeting signal.

Subheading "A cationic amphipathic helix in C-term drives LD targeting" and [Figure 2](#fig2){ref-type="fig"}: CD completely lacks unit in x- and y-axis. Assuming that y-axis corresponds to MRE the negative peaks at 209nm appear to be extremely strong and beyond -35000. Are concentrations correct? The computed numbers of the CD spectrum should be related to the length of the measures peptide. What does 4% b-sheet mean in context of an 18-residue peptide?

Paragraph two, subheading "A cationic amphipathic helix in C-term drives LD targeting" and [Figure 2E](#fig2){ref-type="fig"}: Is the identified stretch of 18 amino acids embedded in a larger helix? [Figure 2E](#fig2){ref-type="fig"} gives the impression of a positive charge and negative charge at the N-and C-term of the helix respectively. Did the authors take care of the fact, that these are not charged NH3+ and COO- groups in context of the entire protein in their figures and MD calculations?

Paragraph two, subheading "A cationic amphipathic helix in C-term drives LD targeting": The in-silico studies show a representation of the process that the helix diffuses into the micelles (assuming that the helix is already formed in the aqueous phase). However, since models were used I would be extremely careful making quantitative statements as \"high affinity\" or \"quickly diffused\" since they are not associated with quantitative numbers. These conclusions would require much more calculations as presented in this paper. Does an arbitrary \'control\' helix e.g. from the N-terminal domain which is not involved in LD targeting not diffuse into the micelle or at a significantly lower pace?

Subheading "LD-LD docking is induced by the formation of CIDEA complexes": The entire section puts forward very strong conclusions based on just one type of experiments. I suggest that other techniques could be used to test the protein-protein interaction.

Paragraph three of the aforementioned subsection: I do not see the CoIP of CIDEA in [Figure 3B](#fig3){ref-type="fig"}.

Single point mutants in the N-terminal domain (R47E, E79Q/D80N) also show major phenotypic effects and should be discussed in more detail, especially in light that 3D structures with high sequence identify in these region are available. Interestingly, the LD pattern of the variants R47E ([Figure 3](#fig3){ref-type="fig"}) compared to R47A and R47Q (Figure 1--figure supplement 1) is drastically different and should be discussed in more detail.

Reviewer 3:

The models developed in this manuscript could explain a lot about brown versus white fat. The concept of physical-chemical based models to explain switching between small FD in BAT and large FD in WAT is reasonably compelling but the work needs more convincing work on supporting the existence of a functioning amphipathic helix and its proposed interactions with PA on the surface of FD or TAG emulsions.

Suggested additional experiments:

1\) Prove interactions of AH, native sequence and lack of interactions of mutated control sequences, with TAG emulsions. The CD data of peptide in solvent is of no help here. If an experiment showing increased helicity with lipid binding can be devised this will be helpful also.

2\) Show that interactions with TAG emulsions increase (or otherwise modified) with addition of PA to surface monolayers.

10.7554/eLife.07485.020

Author response

All three reviewers thought that this manuscript was interesting and that it contained novel and important information governing the biology of lipid droplets in adipocytes. The authors propose that the growth of lipid droplets involves the binding of an amphipathic helix in CIDEA to phosphatidic acid (PA), and that LD pairs are docked by CIDEA trans complexes through contributions of the N-terminal domain and a C-terminal dimerization region. All three reviewers had substantial concerns about the function of the amphipathic helix in CIDEA. Their concerns are listed below and should be addressed. Specifically:

*1) The authors should provide more information regarding the function of this domain, particularly the specificity of the interaction with phosphatidic acid. Many criticisms center on this issue.*

The identification and functional characterization of the amphipathic helix in CIDEA C-term is one of the major strengths of our manuscript and in this revised form we provide substantial new data to further clarify its role in LD targeting and LD enlargement.

The role of the amphipathic helix controlling the LD localization of CIDEA has been further explored using complementary approaches following the reviewers' suggestions: i) By CD spectroscopy we have determined the stabilization of the helical structure through interaction with liposomes of different composition. ii) We have extended our CG-MD simulations by analysing a range of mutant peptides with LDs containing or lacking PA, showing a remarkable concordance with our in vitro and cellular data. iii) We have demonstrated that the conjugation with the 18-amino acid sequence is sufficient to target the soluble N-term fragment of CIDEA into LDs and induce their clustering.

Whereas specific protein-lipid interactions can control the selective membrane translocation of soluble proteins to certain organelles, we do not claim that the interaction of CIDEA and the LD membrane is mediated by PA-binding. In fact, our data clearly indicate that LD-targeting is independent of PA binding. Firstly, we found that some mutants that are incapable of binding PA and promoting LD enlargement can efficiently target the LDs. Secondly, the depletion of PA in LDs by LIPIN-1γ prevents CIDEA-induced LD enlargement but does not affect the LD localization of CIDEA. Thirdly, our CD analysis and GC-MD simulations reveal that interaction with liposomes or modelled LDs does not require the presence of PA.

In addition to its role in LD-targeting, we demonstrate that the amphipathic helix is essential for the LD enlargement step and that this process depends on the interaction of CIDEA with PA through this domain. It is important to emphasise that we are not claiming that CIDEA only binds PA as in this paper we show that it can interact with other phospholipids such as cardiolipin or phosphatidylinositol phosphates. We have focused on PA due to its suggested role in modulating membrane dynamics to facilitate LD enlargement and the recent identification in LDs of enzymes that generate and consume PA (AGPAT3 and LIPIN-1γ). Importantly, our data unequivocally demonstrate that CIDEA can interact with PA and that the presence of PA is necessary for CIDEA activity. PA depletion in yeast and mammalian cell models prevents LD enlargement without affecting the LD localization of CIDEA, and we demonstrate that the amphipathic helix is essential for PA-binding and LD enlargement, as its disruption by truncation of the protein or amino acid substitutions results in the prevention of both processes. Finally, the additional CG-MD simulations of the PA-helix interaction in the context of the LD membrane have been utilized to clarify the potential role of PA in the molecular mechanism of CIDEA action (detailed in [Figure 7](#fig7){ref-type="fig"}).

*2) The reviewers were uncertain about the validity of the experimental systems that were used in this paper. All three reviewers wanted to see experiments that would directly assess the binding of the amphipathic helix (as well as mutant amphipathic helices) to a lipid monolayer at an aqueous interface. The authors should either use liposomes of defined composition or use a variety of oil-water interface systems that have been used to study the biophysical properties of amphipathic helices in other proteins, for example plasma apolipoproteins. These additional studies are important.*

We have instigated successful new biophysical investigations of interactions between CIDEA and lipids. For this we have undertaken analysis of CD spectra of the CIDEA amphipathic helix and a non-amphipathic mutant in aqueous solution and then in the presence of liposomes of different compositions.

In addition we have substantially increased our range of CG-MD simulations, modelling the interaction of wild type and mutant helices with LDs composed of PC:TAG (400:200) and PC:PA:TAG (364:36:200). The different dynamics observed remarkably fit the results of our CD analysis of the peptide interaction with liposomes and the cellular phenotype induced by the different CIDEA mutants, confirming the validity of these simulations for the study of CIDE activity. This has offered novel insights on the nature of CIDEA interaction with PA, complementing our model for the mechanism of action of CIDEA.

*3) The manuscript has a very large amount of information, reflecting considerable work. Many of the figures are impressive. However, it would be helpful to specify how many times each experiment was repeated.*

We have amended the legends and Methods section in the revised manuscript to clarify the number of times and replicates that were performed for each experiment. We have also clearly stated the number of transfected cells assessed for lipid droplet morphology by confocal microscopy per plasmid. The phenotypic distribution was performed in a minimum of three independent experiments for every construct (n \> 50 cells). Although the selection of microscopy images representative of the main phenotype of transfected cells is a common and valid practice in cell biology, we believe our approach, based on the quantification of the different phenotypes observed, has proved more reliable and informative. Together with the analysis of a large number of mutants this has permitted the identification and fine mapping of the different phases of CIDEA activity, providing novel insights for each of these processes:

LD targeting: we demonstrate that CIDEA is docked to the LD membranes by the insertion of an amphipathic helix.

LD-LD docking: by optimising our cellular model to minimize LD clustering independent of CIDEA-CIDEA interactions we have been able to functionally demonstrate the role of the N-term and C-term dimerization sites previously identified in CIDE proteins.

LD enlargement: we demonstrate that independently of its role in LD targeting, the amphipathic helix controls LD enlargement in a process that requires its interaction with PA.

*4) Also, with respect to the western blots, most of them showed only \"cut-out\" bands, and it was not clear whether those bands were taken from the same experiment and the same western blot. Please clarify. And if the bands were taken from different experiments, please discuss how the studies were interpreted.*

The Western Blots referred to by the reviewers addressed protein interactions of wild type and proteins with truncations or amino acid substitutions. Separate Western blots were performed for the different expressed proteins. Our Western Blot analysis is completely valid for assessing protein interactions as each individual protein was always analysed on the same blot as the input of the same protein. The input protein confirms that the exogenously expressed protein was both successfully expressed and detected by Western Blotting and thus, we can definitively determine if there was a direct protein-protein interaction or not. Importantly, for the Co-IPs, where a positive interaction is shown, we have included negative controls, namely IPs from transfected cells in which the epitope-tagged protein targeted by the antibody has been replaced by an empty vector. As no protein was IPed with these controls, it shows that the protein not targeted by the antibody was not capable of being pulled down in the absence of its interacting partner. Therefore, the Co-IPed proteins are only pulled down and detected by Western Blot when a true interaction is present.

*5) Also, as noted by the reviewers, several of the experiments contained an insufficient number of controls.*

In addition to developing a new assay for CIDEA CD spectrometry we have included the additional control of the peptide with substitutions F166R/V169R/L170R which was designed to disrupt its amphipathic nature. Our new data showed that the WT CIDEA amphipathic helix folded in the presence of DLPC liposomes whereas the peptide with amino acid substitutions under the same conditions was not capable of folding to an alpha-helix.

More controls were also requested to demonstrate the specificity of the protein interaction with PA. However, we have clearly shown a physical interaction between CIDEA and PA as well as a functional requirement for the interaction. Furthermore, additional investigations of binding specificity are not a requirement of our mechanistic model and we actually show that CIDEA can interact with other anionic phospholipids. As claimed in the text:

"We utilized lipid strips to investigate the affinity of CIDEA for different lipids present in mammalian cell membranes, finding that it selectively bound a set of anionic phospholipids ([Figure 5A](#fig5){ref-type="fig"})".

Due to its relevance in LDs, the interaction with PA was further analysed using agarose-PA beads, a method that was validated by comparison with agarose-Protein A beads and by competition with soluble PC and PA. Once demonstrated its reliability, the assay was extended to additional CIDE constructs. The functional requirement of PA for CIDEA action was demonstrated in yeast and mammalian cells ([Figure 5](#fig5){ref-type="fig"} and [Figure 6](#fig6){ref-type="fig"}).

For the CG-MD simulations, we agree that additional controls were necessary. In addition to studying the effect of PA and eliminating the peptide terminal charges, we have included simulations with mutant and N-term helices to measure their behaviour in relation to that observed for the wild type.

Reviewer 1:

*\[...\] Overall, this is an excellent to outstanding paper, which reveals new mechanisms in the formation of lipid droplets in adipocytes. The notion that the CIDEA amphipathic helix interacts avidly and specifically to phosphatidic acid is critical for this paper. I believe that the authors should make an attempt to document that the binding of CIDEA to a phospholipid-water interface (with or without triolein) interface and document changes in surface pressure, with the goal of documenting the specificity of the interaction with PA.*

We would like to clarify that we have identified that the LD-enlarging function of CIDEA is dependent on the binding of PA to an amphipathic helix. However, we show that CIDEA can interact with a range of other phospholipids and our proposed mechanism does not exclude that other negatively charged lipids present in LD membranes could contribute to CIDEA activity. However, the key role of PA is clearly demonstrated in the PA depletion experiments, which reveal the functional dependence of CIDEA on PA levels. Further details in our response to the role PA interaction in CIDEA function are outlined in our response to the editor's comments (comment 1).

The measurement of changes in surface pressure in a phospholipid-water interface will help the characterization of the LD-binding process but is beyond the scope of this paper. However, with our new CD assays in the presence or absence of liposomes, we offer alternative biophysical evidence of the interaction between the amphipathic helix and phospholipid membranes. As expected, in line with our previous results showing that LD-targeting and PA-binding are independent processes, the presence of PA in the liposomes was not required for the stabilization of the peptide's helical structure.

Some of the experiments need additional controls. For example, I would like the authors to better document the CD spectra of the mutant helix containing the Glu mutations. How about showing data for the mutant helix in [Figures 2F and 2G](#fig2){ref-type="fig"}?

We considered that the Glu mutations (K167E/R171E/R175E) would not offer an ideal control for the CD experiments. Whereas these mutations prevent LD enlargement and PA-binding, they do not influence the ability of CIDEA to target the LD membranes. In addition, as we did not observe significant differences in the CD profile of the wt helix by the addition of a 10% PA to the PC liposomes, we considered that the analysis of this PA-binding defective mutant would not offer additional information, other to confirm its unaffected folding and interaction with membranes. In contrast, as the CD assay proved a useful tool to analyse the interaction of the amphipathic helix with membranes (regardless of the presence of PA), we decided to analyse the effect of amino acid substitutions impairing LD targeting. In view of the previous results with CIDEA-(L169R/V170R)-v5, we added CIDEA-(F166R/L169R/V170R)-v5 to the LD phenotype analysis, observing impaired LD binding. These amino acid substitutions eliminate the amphipathic nature of the helix, by introducing positive charges in its hydrophobic face. Therefore, we chose the (F166R/V169R/L170R) peptide as a control for our new CD analysis. The new data represent a significant addition to the previous analysis by demonstrating that in the presence of DLPC liposomes, the wild type peptide shows enhanced alpha helical folding whereas the mutated version remains largely unaffected. The new data are presented in [Figure 5](#fig5){ref-type="fig"}.

We acknowledged that the Glu mutant would be a valuable addition to the CG-MD simulations represented in the old [Figures 2F and 2G](#fig2){ref-type="fig"}. The new simulations were performed with different peptides in LDs containing or lacking PA. In line with our previous results with the full length proteins, we observed that both the wt and the (K167E/R171E/R175E) peptides could be embedded in the different LDs, but only the wt could directly interact with the PA molecules. These data are presented in the new [Figure 5](#fig5){ref-type="fig"}.

*Also, this reviewer would like to know more information about the specificity of the amphipathic helix interactions with PA. Would the interaction occur if the Arg residues were replaced with Lys or His, and if the Lys residue were replaced with Arg or His? Please report the conservation of all residues within the helix in vertebrate evolution.*

We have generated additional mutants to address this comment. The new data has been included in [Figure 2](#fig2){ref-type="fig"}. We have included the following text in the Results section to describe the results of the relevant substitutions:

"The absence of negative charges in the helix appeared as essential condition to permit TAG transference \[...\] it can carry a positive charge depending on the pH and local environment which could explain the activity retained by this protein."

We have amended the manuscript to include a figure ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}) reporting the conservation of the amphipathic helix across vertebrate species. We have inserted the following text to describe our new analysis.

"K167 is 100% conserved across all vertebrate species examined. R171 was conserved across vertebrates including birds, snakes, lizards, crocodiles, turtles, marsupials, placental mammals, monotremes, although not in fish. R175 is also highly conserved with only birds, dolphin and Nile Tilapia (a fish) lacking this residue. Remarkably, an amphipathic helix is predicted in CIDEA of all the vertebrate species examined ([Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"})."

Much of the data in the paper appears to be bands cut out of a western. Were all of these experiments performed on the same gel, or multiple gels? If the latter, please explain the controls for each experiment.

The CIDEA protein Western Blots after co-immunoprecipitation were prepared from separate transfections. In these experiments we are addressing whether there is a protein-protein interaction. Therefore, it is necessary to compare the immunoprecipitated protein with the input into the co-IP. Thus, we have included the protein input in the Western Blots, which shows the transfection was successful. A positive control of full-length wild type CIDEA confirmed that both the immunoprecipitation protocol and Western Blotting was successful.

*In [Figure 4B](#fig4){ref-type="fig"}, it would be nice to show additional controls with other anionic phospholipids bound to beads -- and examine competition with other anionic phospholipids. Also, testing the CIDEA mutant with the Glu mutations would be helpful. Similarly, [Figure 4I](#fig4){ref-type="fig"} and [Figure 5L](#fig5){ref-type="fig"} need additional controls.*

Our data clearly show binding of PA to CIDEA using lipid strips and PA-beads. Furthermore, in this assay we show interactions with other anionic phospholipids. We selected PA for further study and demonstrate the functional requirement of PA for the enlargement of LDs by CIDEA in both yeast and mammalian cells. We are not claiming that the CIDEA only binds PA, but demonstrating that binding occurs and this is required for the function of CIDEA. Although we agree that alternative lipid-beads or competition assays with alternative phospholipids could be done to test which other species could bind CIDEA, CIDEC and LIPIN-1γ, or if the Glu mutations selectively interfere with the binding of a subset of them, we consider that this information extends beyond the remit of this paper.

The specificity of the CIDEA interaction with PA in our assays with agarose-PA-beads was verified by the total lack of interaction with agarose-Protein A-beads. The strength of the assay was further validated with competition assays with soluble PA and PC. Once this interaction was confirmed, truncated CIDEA constructs were analysed to identify the regions involved in the interaction, for which we always included the control of the input protein in the same Western as the interaction with the PA beads.

Reviewer 2:

General comments:

*Figure 1--figure supplement 1 is a central figure and should be included in the main text.*

We have now included this figure as main [Figure 2](#fig2){ref-type="fig"}.

*Introduction and subsection "A cationic amphipathic helix in C-term drives LD targeting": I would appreciate a more conservative approach in separating previously existing knowledge from new findings presented in this manuscript (e.g. of 3D structures or LD binding regions).*

The Introduction clearly outlines what are existing and new findings. The aforementioned subsection has been re-written and expanded to more clearly delineate our own analysis from previous findings (with references).

*Subheading "A cationic amphipathic helix in C-term drives LD targeting" and [Figure 2](#fig2){ref-type="fig"}: According to the hypothesis put forward by the authors, the short sequence 162-197 should target the N-terminal domain fused to the LD targeting helix to the LD. This should be shown experimentally and would strongly enhance the sole importance of this helix as targeting signal.*

We have undertaken the proposed experiment which included generation a plasmid to express a protein containing the N-terminal region fused to the region containing the amphipathic helix (HA-CIDEA-(1-117)-(163-180)). The results are shown and confirm that the N-terminal fragment alone did not target LDs whereas when fused to the amphipathic helix the resulting protein was competent in LD targeting and promoted LD clustering. Therefore, in addition to confirming the role of the amphipathic helix in LD targeting this result offers new evidence supporting the LD-LD docking activity of the N-term domain. These data are included in [Figure 3D](#fig3){ref-type="fig"} and described in the modified results section of the manuscript. Importantly, these data provide experimental evidence that our in silico analysis based on the 18-aa helix is a valid approach to model the interaction of CIDEA with the LD membranes.

*Subheading "A cationic amphipathic helix in C-term drives LD targeting" and [Figure 2](#fig2){ref-type="fig"}: CD completely lacks unit in x- and y-axis. Assuming that y-axis corresponds to MRE the negative peaks at 209nm appear to be extremely strong and beyond -35000. Are concentrations correct? The computed numbers of the CD spectrum should be related to the length of the measures peptide. What does 4% b-sheet mean in context of an 18-residue peptide?*

We have revisited the CD spectrum data. The concentration of the protein was measured by absorbance spectroscopy and the fit recalculated as we found the concentration lower than previously calculated based on the weight of the peptide alone. The re-analysed data has been re-plotted with units ∆ε (L mol^-1^ cm^-1^) and is included in [Figure 3C](#fig3){ref-type="fig"} with the fit estimates included in [Figure 5--figure supplement 1](#fig5s1){ref-type="fig"}. The peptides used in the CD study were 28 residues rather than 18 as stated in the Methods and thus also included non-helical flanking regions. The presence of b-sheet may indicate some degree of aggregation in the peptide solutions. Furthermore, peptides taken out of context of their full-length structures usually display a high degree of flexibility and thus display more random coil contributions than predicted based on sequence analysis.

In addition to re-plotting our CD analysis of the CIDEA amphipathic helix in detergent micelles, we also included new analysis of the wild type helix and helix with amino acids substitutions (F166R/V169R/L170R) in the presence or absence of liposomes. The addition of liposomes clearly induces the formation of helix ([Figure 5E](#fig5){ref-type="fig"}). The axes are fully labelled in the graphs included in [Figure 5E](#fig5){ref-type="fig"} and are directly comparable to the detergent micelle spectrum in [Figure 3C](#fig3){ref-type="fig"}. The detailed predictions of all secondary structure elements are provided in [Figure 5--figure supplement 1](#fig5s1){ref-type="fig"}. It is important to note that secondary structure predictions for membrane associated peptides and proteins are qualitative in nature and are included here primarily for ease of comparison and discussion of the data.

Paragraph two, subheading "A cationic amphipathic helix in C-term drives LD targeting" and [Figure 2E](#fig2){ref-type="fig"}: Is the identified stretch of 18 amino acids embedded in a larger helix? [Figure 2E](#fig2){ref-type="fig"} gives the impression of a positive charge and negative charge at the N-and C-term of the helix respectively. Did the authors take care of the fact, that these are not charged NH3+ and COO- groups in context of the entire protein in their figures and MD calculations?

For the CG-MD, the 18 amino acids have been taken as is, without embedding them in a larger helix. This is because the circular dichroism experiments were conducted with a larger peptide that included flanking residues and there was no evidence that this would give rise to a larger helix. Also, the secondary structure predictions ([Figure 3A](#fig3){ref-type="fig"}) do not indicate helix at the N-terminal side, and the C-terminal side only predicts a helical segment again after a break of 4 amino acids. Thus, given that there is no direct structural information that justifies the length of the helix, we only modelled the 18 amino acids that are strongly predicted to be helix. The reviewer is correct in noting the charges, and these have been omitted in the new simulations. Although the overall conclusions are not affected and the helix still binds to the lipid droplet, binding is now improved when PA was added to the system, in line with the experimental results.

*Paragraph two, subheading "A cationic amphipathic helix in C-term drives LD targeting": The in-silico studies show a representation of the process that the helix diffuses into the micelles (assuming that the helix is already formed in the aqueous phase). However, since models were used I would be extremely careful making quantitative statements as \"high affinity\" or \"quickly diffused\" since they are not associated with quantitative numbers. These conclusions would require much more calculations as presented in this paper. Does an arbitrary \'control\' helix e.g. from the N-terminal domain which is not involved in LD targeting not diffuse into the micelle or at a significantly lower pace?*

We have performed additional simulations with different helices to assess their relative affinity for the LD. In concordance with our cellular assays, we have confirmed that both the wild type and the K167E/R171E/R175E form a stable interaction with the LD and are embedded in the phospholipid monolayer. In contrast no LD binding was observed with the non-amphipathic mutants F166R/V169R/L170R. As suggested, we have included a control N-term helix, which did not interact with the LD. In concordance with the CD analysis in liposomes, the addition of 10% PA to the modelled LD rescues the impaired LD-targeting of F166R/V169R/170R, although it displays a superficial docking, confirming the importance of the helix amphipathic nature for its insertion in the LD membrane. The confirmation of the predicted behaviour of the different helices strongly supports the validity of this experimental approach to study the mechanism of action of CIDEA at the molecular level. We have not used quantitative statements such as "high affinity" or "quickly diffused" in our description of the new CG-MD data.

*Subheading "LD-LD docking is induced by the formation of CIDEA complexes": The entire section puts forward very strong conclusions based on just one type of experiments. I suggest that other techniques could be used to test the protein-protein interaction.*

We have based our conclusions on two complementary approaches, namely Co-IP and confocal microscopy to determine LD-LD docking. The Co-IP is a reliable assay for determination of protein-protein interactions. Other assays such as GST pulldowns would not reveal additional mechanistic insight into the protein-protein interactions we have demonstrated. The dimerization of the N-term fragments of CIDE proteins had been previously characterized by NMR, X-ray crystallography, co-IP, and gel filtration assays, as referenced in the manuscript. The novelty of our approach is the combination of the co-IP data, to test the existence of interactions with the LD-LD docking analysis. This has provided the functional demonstration of the hypothesized role of CIDEA-CIDEA interactions in LD-LD docking, and has revealed that both the N-term and C-term dimerization sites can contribute to this process. To achieve this goal, our cell culture model was optimized to reduce the presence of spontaneous LD clusters to facilitate the study of CIDEA-induced LD clustering by the identification of LD-LD docking defective mutants. Numerous endogenous LD clusters are observed in undifferentiated 3T3-L1 cells, which have been previously used for functional studies on CIDE proteins. In contrast, our Hela cells contained few LDs in basal conditions, and LD formation was induced by BSA-oleate treatment 24 hours after transfection. The newly formed LDs were dispersed thorough the cytoplasm and were targeted by the different CIDEA constructs already present, which could promote their docking and enlargement during a short period of time before fixation (18 hours). This experimental setting largely prevented the LD-LD docking activity by endogenous LD proteins, allowing the disclosure of LD-LD docking defective CIDEA mutants.

Our new studies with HA-(1-117)-(163-180) offer additional evidence on the role of the N-term domain in LD-LD docking, showing the appearance of LD clusters when the soluble N-term fragment is directed to the LD membranes by the amphipathic helix.

*Paragraph three of the aforementioned subsection: I do not see the CoIP of CIDEA in [Figure 3B](#fig3){ref-type="fig"}.*

This data has been included in the revised manuscript (now in [Figure 4B](#fig4){ref-type="fig"}).

*Single point mutants in the N-terminal domain (R47E, E79Q/D80N) also show major phenotypic effects and should be discussed in more detail, especially in light that 3D structures with high sequence identify in these region are available. Interestingly, the LD pattern of the variants R47E ([Figure 3](#fig3){ref-type="fig"}) compared to R47A and R47Q (Figure 1--figure supplement 1) is drastically different and should be discussed in more detail.*

We have discussed in more detail the effects of amino acid substitutions in the context of the CIDE-N domain in light of its 3D structure and in relation to CIDEC. The following passage was included in the manuscript:

"The lack of co-IP between the N-term fragment and the full length CIDEA could be due to conformational and positional factors \[...\] the N-term domain of CIDEA can contribute to LD-LD docking by forming complexes with its counterparts on the adjacent LD."

Reviewer 3:

Suggested additional experiments:

*1) Prove interactions of AH, native sequence and lack of interactions of mutated control sequences, with TAG emulsions. The CD data of peptide in solvent is of no help here. If an experiment showing increased helicity with lipid binding can be devised this will be helpful also.*

We thank the reviewer for this suggestion. We have undertaken new CD analysis of CIDEA peptides in aqueous buffer in the absence and presence of liposomes. These data show that helicity of the CIDEA AH is enhanced in the presence of liposomes. Significantly, we show that amino acid substitutions that eliminate the amphipathic nature of the helix reduce helical folding even in the presence of liposomes (DLPC).

2\) Show that interactions with TAG emulsions increase (or otherwise modified) with addition of PA to surface monolayers.

We were indeed able to show that with CD analysis while DLPC liposomes were unable to promote folding of the CIDEA helix with amino acids substitutions F166R/V169R/L170R (designed to eliminate the amphipathic nature due to additional charge of R compared to the hydrophobic residues in the WT), DLPA:DLPC (1:9) liposomes were able to facilitate helical folding.

Using CG-MD simulations to model the molecular dynamics of the helix-LD interaction we have observed that PA is not required for LD targeting, confirming our previous observations separating PA-binding from LD-targeting. However we have observed a faster interaction of the wt helix with LDs containing PA. Remarkably we have observed the direct interaction of PA with the polar residues of the wt helix, whereas the inactive K167E/R171E/R175E avoids the PA molecules. This has offered further evidence to support our molecular model for the activity of CIDEA.
